McDermott + Bull Partner Ken Dropiewski sits down with KCK Group’s Senior Managing Director Greg Garfield to explore essential topics for investors in the MedTech space. Greg provides an inside look at KCK Group’s typical investment and team structure, as well as his journey into investing and outlook for 2025.
Investor Insights: Ken Dropiewski with Greg Garfield, Senior Managing Director at KCK Group
